LJ10 LLC - 09 Dec 2022 Form 4 Insider Report for Pear Therapeutics, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Dec 2022, 17:00:11 UTC
Prior SEC filing
08 Dec 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
LJ10 LLC, By: /s/ Elon S. Boms, as Manager
Filing notes and source

Key filing fact

LJ10 LLC filed Form 4 for Pear Therapeutics, Inc. on 13 Dec 2022.

Key facts

  • This page summarizes LJ10 LLC's Form 4 filing for Pear Therapeutics, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Dec 2022, 17:00.

Change

  • Previous filing in this sequence was filed on 08 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PEARQ transaction

Class A Common Stock

Other

Transaction value
$0
Shares
-430,000
Change %
-6.6%
Price
$0.000000
Shares after
6,110,000
Date
09 Dec 2022
Ownership
Direct
Footnotes
F1, F2
PEARQ holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,387,026
Date
09 Dec 2022
Ownership
Direct
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares of Class A common stock, par value $0.0001 per share (the "Common Stock"), of the Issuer distributed by LJ10 LLC (the "Sponsor") to its members for no consideration. Elon S. Boms and two other managers are the three managers of the Sponsor's board of managers. Any action by the Sponsor with respect to the Issuer or the Common Stock, including voting and dispositive decisions, requires at least a majority vote of the managers of the board of managers. Under the so-called "rule of three", because voting and dispositive decisions are made by a majority of the managers, none of the named managers is deemed to be a beneficial owner of securities held by the Sponsor, even those in which such manager may hold a pecuniary interest. Accordingly, none of the managers on the Sponsor's board of managers is deemed to have or share beneficial ownership of the shares of Common Stock held by the Sponsor.

Footnote F2

KLP SPAC 1 LLC and the Sponsor may be deemed to be members of a "group," within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, comprised of the KLP SPAC 1 LLC and the Sponsor.

Footnote F3

Represents shares of Common Stock held by KLP SPAC 1 LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .